Nutrien (NYSE:NTR - Get Free Report) had its price target lifted by research analysts at Morgan Stanley from $77.00 to $93.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. Morgan Stanley's target price indicates a potential upside of 28.96% from the company's previous close.
A number of other brokerages have also commented on NTR. TD Securities increased their price target on shares of Nutrien from $80.00 to $81.00 and gave the stock a "buy" rating in a report on Tuesday, February 17th. UBS Group lowered shares of Nutrien from a "neutral" rating to a "sell" rating and upped their target price for the stock from $63.00 to $67.00 in a research report on Thursday, March 26th. Oppenheimer increased their target price on Nutrien from $76.00 to $78.00 and gave the company an "outperform" rating in a research note on Thursday, February 26th. Weiss Ratings upgraded Nutrien from a "hold (c)" rating to a "buy (b-)" rating in a research report on Monday, March 2nd. Finally, JPMorgan Chase & Co. lifted their price target on Nutrien from $68.00 to $78.00 and gave the stock an "overweight" rating in a research note on Friday, February 20th. Eleven investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $78.50.
View Our Latest Stock Analysis on NTR
Nutrien Price Performance
Shares of NTR traded down $4.77 during mid-day trading on Wednesday, reaching $72.11. 771,656 shares of the stock traded hands, compared to its average volume of 3,660,814. The firm has a fifty day moving average price of $73.94 and a 200 day moving average price of $64.93. The company has a market cap of $34.69 billion, a price-to-earnings ratio of 15.37 and a beta of 0.69. The company has a current ratio of 1.34, a quick ratio of 0.70 and a debt-to-equity ratio of 0.37. Nutrien has a 1 year low of $46.50 and a 1 year high of $85.36.
Nutrien (NYSE:NTR - Get Free Report) last posted its earnings results on Wednesday, February 18th. The company reported $0.83 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.04). Nutrien had a return on equity of 8.41% and a net margin of 8.43%.The business had revenue of $5.12 billion for the quarter, compared to analysts' expectations of $5.26 billion. During the same quarter in the previous year, the firm earned $0.31 earnings per share. Nutrien's quarterly revenue was up 5.1% compared to the same quarter last year. As a group, equities research analysts predict that Nutrien will post 3.72 earnings per share for the current year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Wellington Management Group LLP lifted its stake in shares of Nutrien by 440.2% in the 4th quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company's stock valued at $1,008,713,000 after acquiring an additional 13,313,817 shares during the last quarter. Norges Bank bought a new position in Nutrien during the 4th quarter worth approximately $412,635,000. Arrowstreet Capital Limited Partnership increased its stake in Nutrien by 19.1% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 14,221,381 shares of the company's stock worth $834,962,000 after purchasing an additional 2,276,651 shares during the period. TD Asset Management Inc lifted its position in Nutrien by 21.2% in the fourth quarter. TD Asset Management Inc now owns 8,928,534 shares of the company's stock valued at $551,821,000 after purchasing an additional 1,559,673 shares during the last quarter. Finally, OMERS ADMINISTRATION Corp boosted its stake in shares of Nutrien by 5,891.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,240,184 shares of the company's stock valued at $76,650,000 after purchasing an additional 1,219,484 shares during the period. 63.10% of the stock is owned by institutional investors.
About Nutrien
(
Get Free Report)
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.